BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36581086)

  • 1. The phytochemical curcumin inhibits steroid sulfatase activity in rat liver tissue and NIH-3T3 mouse fibroblast cells.
    Balasubramonian B; Selcer KW
    Steroids; 2023 Mar; 191():109163. PubMed ID: 36581086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid sulfatase in the mouse NIH-3T3 fibroblast cell line: Characterization, and downregulation by glucocorticoids.
    Selcer K; Balasubramonian B; Miller D; Kerr J; DiFrancesco M; Ojha S; Urbano R
    Steroids; 2021 Oct; 174():108890. PubMed ID: 34280393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy.
    Foster PA; Newman SP; Chander SK; Stengel C; Jhalli R; Woo LL; Potter BV; Reed MJ; Purohit A
    Clin Cancer Res; 2006 Sep; 12(18):5543-9. PubMed ID: 17000691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase.
    Hejaz HA; Woo LW; Purohit A; Reed MJ; Potter BV
    Bioorg Med Chem; 2004 May; 12(10):2759-72. PubMed ID: 15110857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of dehydroepiandosterone sulfate action in androgen-sensitive tissues by EM-1913, an inhibitor of steroid sulfatase.
    Roy J; Lefebvre J; Maltais R; Poirier D
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):148-55. PubMed ID: 23806558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic steroid sulfatase critically determines estrogenic activities of conjugated equine estrogens in human cells
    Feng Y; Xie Y; Xu M; Li L; Selcer KW; Oberly PJ; Poloyac SM; Wang H; Li C; Dong F; Yu C; Xie W
    J Biol Chem; 2019 Aug; 294(32):12112-12121. PubMed ID: 31217279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid sulfatase activity in the rat ovary, cultured granulosa cells, and a granulosa cell line.
    Clemens JW; Kabler HL; Sarap JL; Beyer AR; Li PK; Selcer KW
    J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):245-52. PubMed ID: 11282278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models.
    Ishida H; Nakata T; Suzuki M; Shiotsu Y; Tanaka H; Sato N; Terasaki Y; Takebayashi M; Anazawa H; Murakata C; Li PK; Kuwabara T; Akinaga S
    Breast Cancer Res Treat; 2007 Dec; 106(2):215-27. PubMed ID: 17268815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel steroid sulfatase inhibitors. I. Synthesis and biological evaluation of biphenyl-4-O-sulfamates.
    Okada M; Nakagawa T; Iwashita S; Takegawa S; Fujii T; Koizumi N
    J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):141-8. PubMed ID: 14672734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats.
    Saito T; Kinoshita S; Fujii T; Bandoh K; Fuse S; Yamauchi Y; Koizumi N; Horiuchi T
    J Steroid Biochem Mol Biol; 2004 Feb; 88(2):167-73. PubMed ID: 15084348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid derivatives as inhibitors of steroid sulfatase.
    Mostafa YA; Taylor SD
    J Steroid Biochem Mol Biol; 2013 Sep; 137():183-98. PubMed ID: 23391659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer.
    Foster PA; Chander SK; Parsons MF; Newman SP; Woo LW; Potter BV; Reed MJ; Purohit A
    Breast Cancer Res Treat; 2008 Sep; 111(1):129-38. PubMed ID: 17914670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid sulfatase inhibitors: the current landscape.
    Anbar HS; Isa Z; Elounais JJ; Jameel MA; Zib JH; Samer AM; Jawad AF; El-Gamal MI
    Expert Opin Ther Pat; 2021 Jun; 31(6):453-472. PubMed ID: 33783295
    [No Abstract]   [Full Text] [Related]  

  • 14. Steroid sulfatase mediated growth Sof human MG-63 pre-osteoblastic cells.
    Dias NJ; Selcer KW
    Steroids; 2014 Oct; 88():77-82. PubMed ID: 25042472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of 3-benzylaminocoumarin-7-O-sulfamate derivatives as steroid sulfatase inhibitors.
    Hng Y; Lin MH; Lin TS; Liu IC; Lin IC; Lu YL; Chang CN; Chiu PF; Tsai KC; Chen MJ; Liang PH
    Bioorg Chem; 2020 Mar; 96():103618. PubMed ID: 32059152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid sulfatase inhibitors.
    Nussbaumer P; Billich A
    Med Res Rev; 2004 Jul; 24(4):529-76. PubMed ID: 15170594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
    Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisulfatase, Osteogenic, and Anticancer Activities of Steroid Sulfatase Inhibitor EO-33 in Mice.
    Poirier D; Roy J; Maltais R; Ayan D
    J Med Chem; 2019 Jun; 62(11):5512-5521. PubMed ID: 31062594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
    Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
    J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy.
    Day JM; Purohit A; Tutill HJ; Foster PA; Woo LW; Potter BV; Reed MJ
    Ann N Y Acad Sci; 2009 Feb; 1155():80-7. PubMed ID: 19250195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.